Sugi Holdings Lifts FY2026 Forecast on Strong Revenue and Profit Growth
Sugi Holdings Co., Ltd. (スギホールディングス株式会社) (TSE:7649) reported robust financial results for its full fiscal year ending February 2026, driven by strong revenue growth and a significant increase in net profit. Management is projecting continued expansion in the coming year.
The company, which operates a chain of drugstores under the "Sugi Yakkyoku" brand with a focus on pharmacies integrated into its stores, reported revenue of JPY 1010.3bn, a 15.1% year-over-year increase. Operating profit rose 14.1% to JPY 48.6bn, while ordinary income increased 19.2% to JPY 50.1bn. Most notably, net profit surged 75.1% to JPY 45.0bn, reflecting a combination of improved operating performance and non-operating gains.
Key Numbers (JPY bn)
| Metric | FY2026 (Actual) | YoY Change |
|---|---|---|
| Revenue | 1,010.3 | +15.1% |
| Operating Profit | 48.6 | +14.1% |
| Ordinary Income | 50.1 | +19.2% |
| Net Profit | 45.0 | +75.1% |
| Operating Margin | 4.8% | — |
| Equity Ratio | 47.3% | — |
Business Overview
Sugi Holdings is a leading player in the Japanese retail pharmacy sector, with a strong presence in the Chubu region. The company's competitive edge lies in its integrated pharmacy model, which combines retail drugstore services with prescription dispensing, catering to the growing demand for healthcare and pharmaceutical products in Japan's aging population.
Analysis
The 15.1% year-over-year increase in revenue aligns with broader industry trends, as the demand for healthcare-related products and services continues to rise. Sugi's strength in pharmacies with integrated dispensing services has likely contributed to this growth, as these stores are well-positioned to capture market share in a sector experiencing increased consumer spending on health and wellness.
However, the company's operating margin of 4.8% lags behind the industry average of 6.0%, suggesting that Sugi may be facing cost pressures or competitive pricing challenges. This margin pressure is a key area to monitor, as it could impact long-term profitability if not addressed.
The 19.2% increase in ordinary income was driven not only by higher operating profits but also by a significant improvement in non-operating income, including gains from investments. This includes an 80% year-over-year increase in "including profit" (including profit, or kakuritsu rieki), which reflects gains from equity investments and other financial instruments.
The most striking result was the 75.1% surge in net profit, which was largely attributable to the aforementioned non-operating gains and an improvement in the equity ratio to 47.3%. While this is a positive development, the company's reliance on non-operating income...